KLSE:MHCARE

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Metro Healthcare Berhad

Market Cap

RM215.8m

Last Updated

2021/07/30 11:11 UTC

Data Sources

Company Financials

Executive Summary

Metro Healthcare Berhad, an investment holding company, provides hospital and related consultation services in Malaysia. More Details


Snowflake Analysis

Excellent balance sheet with solid track record.

Share Price & News

How has Metro Healthcare Berhad's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: Insufficient data to determine MHCARE's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine MHCARE's volatility change over the past year.


Market Performance


7 Day Return

2.9%

MHCARE

-0.3%

MY Healthcare

-1.0%

MY Market


1 Year Return

7.1%

MHCARE

9.4%

MY Healthcare

-0.7%

MY Market

Return vs Industry: MHCARE underperformed the MY Healthcare industry which returned 9.4% over the past year.

Return vs Market: MHCARE exceeded the MY Market which returned -0.7% over the past year.


Shareholder returns

MHCAREIndustryMarket
7 Day2.9%-0.3%-1.0%
30 Day-8.7%4.7%-0.4%
90 Dayn/a6.7%-5.9%
1 Year7.8%7.1%10.3%9.4%3.0%-0.7%
3 Year193.5%183.8%1.3%-1.0%-2.8%-12.0%
5 Yearn/a-7.8%-11.1%9.8%-8.7%

Long-Term Price Volatility Vs. Market

How volatile is Metro Healthcare Berhad's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Metro Healthcare Berhad undervalued compared to its fair value and its price relative to the market?

39.9%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: MHCARE (MYR1.05) is trading below our estimate of fair value (MYR1.75)

Significantly Below Fair Value: MHCARE is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: MHCARE is good value based on its PE Ratio (38.7x) compared to the MY Healthcare industry average (56.8x).

PE vs Market: MHCARE is poor value based on its PE Ratio (38.7x) compared to the MY market (17.1x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate MHCARE's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: MHCARE is overvalued based on its PB Ratio (9.4x) compared to the MY Healthcare industry average (3x).


Future Growth

How is Metro Healthcare Berhad forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

20.3%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Metro Healthcare Berhad has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Metro Healthcare Berhad performed over the past 5 years?

10.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: MHCARE has a large one-off gain of MYR1.9M impacting its December 31 2020 financial results.

Growing Profit Margin: MHCARE's current net profit margins (19.3%) are higher than last year (10%).


Past Earnings Growth Analysis

Earnings Trend: MHCARE's earnings have grown by 10.5% per year over the past 5 years.

Accelerating Growth: MHCARE's earnings growth over the past year (142.3%) exceeds its 5-year average (10.5% per year).

Earnings vs Industry: MHCARE earnings growth over the past year (142.3%) exceeded the Healthcare industry -7.8%.


Return on Equity

High ROE: MHCARE's Return on Equity (24.1%) is considered high.


Financial Health

How is Metro Healthcare Berhad's financial position?


Financial Position Analysis

Short Term Liabilities: MHCARE's short term assets (MYR11.7M) exceed its short term liabilities (MYR4.2M).

Long Term Liabilities: MHCARE's short term assets (MYR11.7M) exceed its long term liabilities (MYR11.1M).


Debt to Equity History and Analysis

Debt Level: MHCARE's debt to equity ratio (16.1%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if MHCARE's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: MHCARE's debt is well covered by operating cash flow (199.9%).

Interest Coverage: MHCARE's interest payments on its debt are well covered by EBIT (18.3x coverage).


Balance Sheet


Dividend

What is Metro Healthcare Berhad current dividend yield, its reliability and sustainability?

0.62%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: MHCARE's dividend (0.62%) isn’t notable compared to the bottom 25% of dividend payers in the MY market (1.49%).

High Dividend: MHCARE's dividend (0.62%) is low compared to the top 25% of dividend payers in the MY market (4.17%).


Stability and Growth of Payments

Stable Dividend: MHCARE is not paying a notable dividend for the MY market, therefore no need to check if payments are stable.

Growing Dividend: MHCARE is not paying a notable dividend for the MY market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: MHCARE is not paying a notable dividend for the MY market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MHCARE's dividend in 3 years as they are not forecast to pay a notable one for the MY market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

10.3yrs

Average board tenure


CEO

Wai Lim (54 yo)

5.5yrs

Tenure

Mr. Lim Wai Khong is the Managing Director of Metro Healthcare Berhad since 2016 and has been its Director April 29,2011 . Mr. Khong has gained invaluable experience in management fundamentals during his y...


Board Members

Experienced Board: MHCARE's board of directors are seasoned and experienced ( 10.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Metro Healthcare Berhad's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Metro Healthcare Berhad
  • Ticker: MHCARE
  • Exchange: KLSE
  • Founded: 2010
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: RM215.849m
  • Shares outstanding: 205.57m
  • Website: https://metro.com.my

Location

  • Metro Healthcare Berhad
  • No. 36, Jalan Pasar
  • Klang
  • Selangor
  • 41400
  • Malaysia

Listings


Biography

Metro Healthcare Berhad, an investment holding company, provides hospital and related consultation services in Malaysia. The company provides inpatient services, outpatient services, and ambulatory care se...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/07/30 11:11
End of Day Share Price2021/07/26 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.